S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
Log in
NASDAQ:LIFE

aTyr Pharma SEC Filings & 10K Form

$4.35
+0.13 (+3.08 %)
(As of 03/8/2021 04:43 PM ET)
Add
Compare
Today's Range
$4.20
Now: $4.35
$4.53
50-Day Range
$3.53
MA: $4.80
$8.06
52-Week Range
$2.13
Now: $4.35
$8.33
Volume419,716 shs
Average Volume1.14 million shs
Market Capitalization$44.30 million
P/E RatioN/A
Dividend YieldN/A
Beta2.17

SEC Filings

aTyr Pharma (NASDAQ:LIFE) SEC Filings

DateFilerForm TypeView
02/17/2021
5:10 AM
Aspire Capital Fund, LLC (Filed by)
aTyr Pharma (Subject)
Form SC 13G
02/16/2021
10:21 AM
Alyeska Investment Group, L.P. (Filed by)
aTyr Pharma (Subject)
Form SC 13G
02/12/2021
12:17 PM
aTyr Pharma (Subject)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
02/09/2021
8:15 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
8:12 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:16 PM
aTyr Pharma (Filer)
Form 424B5
02/08/2021
7:18 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
7:13 PM
aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
7:08 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
9:15 AM
aTyr Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/25/2021
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2021
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2021
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
8:01 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
3:20 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/23/2020
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
11/13/2020
4:24 PM
aTyr Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/02/2020
4:11 PM
aTyr Pharma (Filer)
Form 424B3
09/28/2020
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
09/18/2020
3:26 PM
aTyr Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/14/2020
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
8:47 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2020
8:09 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:40 PM
aTyr Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2020
3:05 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2020
3:27 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
7:26 PM
aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
7:22 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
7:17 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
7:13 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
3:19 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2020
3:16 PM
aTyr Pharma (Filer)
Form 424B5
05/12/2020
4:06 PM
aTyr Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2020
4:14 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
4:08 PM
aTyr Pharma (Issuer)
Lucas Svetlana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
7:35 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2020
3:16 PM
aTyr Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2020
4:13 PM
aTyr Pharma (Filer)
Form PRE 14A
02/28/2020
4:16 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
1:46 PM
Altium Capital Management LP (Filed by)
aTyr Pharma (Subject)
Form SC 13G
02/12/2020
1:41 PM
aTyr Pharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/11/2020
12:27 PM
aTyr Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
02/11/2020
10:58 AM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:37 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:34 PM
aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:30 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2020
4:31 PM
aTyr Pharma (Filer)
Form 424B4
02/05/2020
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
02/05/2020
8:53 PM
aTyr Pharma (Filer)
Form POS EX
02/05/2020
8:48 PM
aTyr Pharma (Filer)
Form S-1MEF
02/03/2020
7:01 AM
aTyr Pharma (Filer)
Form S-1/A
01/27/2020
7:03 AM
aTyr Pharma (Filer)
Form S-1/A
01/17/2020
7:03 AM
aTyr Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/14/2020
4:28 PM
Alta Partners VIII, L.P. (Filed by)
aTyr Pharma (Subject)
Form SC 13G/A
01/06/2020
8:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
7:10 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
3:05 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
8:46 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
3:44 PM
aTyr Pharma (Subject)
Polaris Venture Partners V, L.P. (Filed by)
Form SC 13D/A
07/10/2019
1:58 PM
aTyr Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/02/2019
4:11 PM
aTyr Pharma (Issuer)
Lucas Svetlana (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2019
4:09 PM
aTyr Pharma (Issuer)
Gross Jane A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2019
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
3:15 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2019
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
06/18/2019
4:28 PM
aTyr Pharma (Filer)
Form S-3/A
06/10/2019
10:51 AM
aTyr Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
05/21/2019
8:56 PM
aTyr Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/21/2019
7:45 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
7:43 PM
aTyr Pharma (Filer)
Form 424B5
05/20/2019
3:38 PM
aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
3:15 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
6:40 PM
aTyr Pharma (Issuer)
BLAIR JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:35 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:29 PM
aTyr Pharma (Issuer)
MENDLEIN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:22 PM
aTyr Pharma (Issuer)
Hatfield Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:06 PM
aTyr Pharma (Issuer)
Coughlin Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:01 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:11 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2019
1:42 PM
aTyr Pharma (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
Form SC 13G
04/16/2019
3:57 PM
aTyr Pharma (Subject)
SCHIMMEL PAUL (Filed by)
Form SC 13D/A
04/16/2019
3:31 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
7:30 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
7:16 AM
aTyr Pharma (Filer)
Form 424B5
03/28/2019
3:15 PM
aTyr Pharma (Filer)
Form DEFA14A
03/28/2019
3:12 PM
aTyr Pharma (Filer)
Form DEFA14A
03/28/2019
3:00 PM
aTyr Pharma (Filer)
Form DEF 14A
03/26/2019
4:28 PM
aTyr Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2019
3:15 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
3:59 PM
aTyr Pharma (Filer)
Form PRE 14A
02/12/2019
3:30 PM
Alta Partners VIII, L.P. (Filed by)
aTyr Pharma (Subject)
Form SC 13G/A
02/08/2019
7:12 PM
aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
7:06 PM
aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2019
6:16 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
6:09 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
4:18 PM
aTyr Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
12/26/2018
3:15 PM
aTyr Pharma (Issuer)
MENDLEIN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.